Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: Northern Territory perspectives on heart failure with comorbidities - understanding trial validity and exploring collaborative opportunities to broaden the evidence base
Author: Iyngkaran, P.
Majoni, W.
Cass, A.
Sanders, P.
Ronco, C.
Brady, S.
Kangaharan, N.
Ilton, M.
Hare, D.
Thomas, M.
Citation: Heart Lung and Circulation, 2015; 24(6):536-543
Publisher: Elsevier
Issue Date: 2015
ISSN: 1443-9506
Statement of
P. Iyngkaran, W. Majoni, A. Cass, Prashanthan Sanders, C. Ronco, S. Brady, N. Kangaharan, M. Ilton, D.L. Hare, M.C. Thomas
Abstract: Congestive Heart Failure (CHF) is an ambulatory care sensitive condition, associated with significant morbidity and mortality, rarely with cure. Outpatient based pharmacological management represents the main and most important aspect of care, and is usually lifelong. This narrative styled opinion review looks at the pharmacological agents recommended in the guidelines in context of the Northern Territory (NT) of Australia. We explore the concept of validity, a term used to describe the basis of standardising a particular trial or study and the population to which it is applicable. We aim to highlight the problems of the current guidelines based approach. We also present alternatives that could utilise the core principles from major trials, while incorporating regional considerations, which could benefit clients living in the NT and remote Australia.
Keywords: Guidelines
Heart Failure
Indigenous Australians
Rights: Copyright © 2015 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ).
DOI: 10.1016/j.hlc.2014.12.007
Appears in Collections:Aurora harvest 7
Medicine publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.